Dr. Bart Emmer, MD, PhD (m), is an interventional neuroradiologist in Amsterdam UMC and a board member of the subsection of neuroradiology of the Dutch society of radiology and Dutch delegate for the UEMS (Neuroradiology). He is the principal investigator of AIRBORNE, (Artificial Intelligence for early imaging Based patient selection in acute ischemic stroke), and CLEOPATRA, a healthcare evaluation study into the cost-effectiveness of CT perfusion in the selection of stroke patients for endovascular treatment. He is local investigator in several stroke trials (ESCAPE NEXT, CASES, MRCLEAN NO-IV, MRCLEAN MED, TECNO) and has been involved in MR CLEAN, BASICS, ECST-2, TESLA, TO-ACT and MR CLEAN LATE trial. He has authored more than 170 articles. (H-index of 34).

Non-Contrast Flat-Panel CT After Thrombectomy

Flat-panel CT (FPCT) in the angiography suite represents a significant advancement in post-endovascular thrombectomy (EVT) assessment for acute stroke patients. This technology eliminates the need for patient transport to conventional CT, reducing time-to-imaging from 30-45 minutes to 2-5 minutes. FPCT provides high spatial resolution imaging capable of detecting hemorrhagic complications with high sensitivity and specificity compared to conventional CT. Clinical applications include immediate assessment of hemorrhage, recanalization status, infarct evaluation, and device-related complications. Despite limitations in soft tissue contrast and artifacts, FPCT enables critical real-time decision-making that can impact patient management in- and outside the angio-suite. Implementation should require standardized protocols, basic staff training, and some form of quality assurance measures. Future developments include AI integration, possibly enabling automated detection of haemorrhagic complications, enhancement of image quality and quantitative assessment of recanalization and infarct volumes. By streamlining workflow and enhancing patient safety, FPCT technology has the potential to become an essential component of comprehensive stroke centres worldwide.